DARZALEX^® may help you live longer without your multiple myeloma getting worse. Combination regimens with DARZALEX^® has been proven effective in multiple clinical studies—even for those who have failed certain previous treatments.

See how DARZALEX^® was studied

• I am newly diagnosed and cannot receive a stem cell transplant that uses my own stem cells (autologous stem cell transplant)
  Learn about the DARZALEX^® + Revlimid^® (lenalidomide) + dexamethasone clinical trial
  Learn about the DARZALEX^® + Velcade^® (bortezomib) + melphalan + prednisone clinical trial
• I am newly diagnosed and can receive a stem cell transplant that uses my own stem cells

  Learn about the DARZALEX^® + Velcade^® (bortezomib) + thalidomide + dexamethasone clinical trial

• I have received at least one prior medicine to treat my multiple myeloma
  Learn about the DARZALEX^® + Revlimid^® (lenalidomide) + dexamethasone clinical trial
  Learn about the DARZALEX^® + Velcade^® (bortezomib) + dexamethasone clinical trial
• I have received at least two prior medicines to treat my multiple myeloma, including Revlimid^® (lenalidomide) and a proteasome inhibitor

  Learn about the DARZALEX^® + Pomalyst^® (pomalidomide) + dexamethasone clinical trial

• I have received at least three prior medicines to treat my multiple myeloma, including a proteasome inhibitor and an immunomodulatory agent, or a proteasome inhibitor and an immunomodulatory agent did not work for me

  Learn about the DARZALEX^® monotherapy clinical trial